Skip to content


  • Poster presentation
  • Open Access

Investigation of the role of Ras and other signaling kinases on the regulation of pyruvate dehydrogenase complex activity

  • 1,
  • 1 and
  • 1
Cancer & Metabolism20142 (Suppl 1) :P20

  • Published:


  • Melanoma
  • Pyruvate Dehydrogenase
  • Pyruvate Dehydrogenase Complex
  • Glutamine Metabolism
  • Lung Tumor Cell

Mutations in K-Ras commonly occur in colorectal, pancreatic and lung cancer, whereas mutations in BRAF are frequently found in melanomas. In past years, several studies have pointed to the role of Ras/Raf in the control of several metabolism pathways including glycolysis, mitochondrial respiration and glutamine metabolism [14]. The PDC complex is one of the central enzymes in the aerobic metabolism which converts the pyruvate produced during the glycolysis into Acetyl CoA used in the TCA cycle. In this work we show a pronounced sensitivity to PDHK-4 depletion in different mutant K-Ras cell lines, resulting in an increase of cell death and inhibition of cell growth in colorectal and lung tumor cell lines. Interestingly, cells expressing wild type K-Ras were signifinantly resistant to PDHK-4 depletion. This sensitivity in mutant Ras cells was correlated with a decrease in ERK phosphorylation, suggesting a possible inactivation in the Ras signaling pathway after PDHK-4 knock-down. Further studies will allow us to understand the biological mechanism by which Ras function is affecting the metabolic pathways involved in the regulation of PDC complex in cancer cells. Understanding the link between the PDC complex and Ras could be relevant to target cancer progression more effectively.

Authors’ Affiliations

Oncology, Astrazeneca, Macclesfield, UK


  1. Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Willson JK, Markowitz S, Zhou S, Diaz LA, Velculescu VE, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N, Phillips DH, Garte S: Glucose deprivation contributes to the development of KRASpathway mutations in tumor cells. Science. 2009, 325: 1555-1560. 10.1126/science.1174229.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Ying H, Kimmelman AC, Lyssiotis CA, et al: Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012, 49: 656-View ArticleGoogle Scholar
  3. Son J, Lyssiotis CA, Ying H, et al: Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway. Nature. 2013, 496: 101-105. 10.1038/nature12040.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Yumin Hu, Weiqin Lu, Gang Chen, et al: K-rasG12V transformatio leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Research. 2012, 22: 399-412. 10.1038/cr.2011.145.View ArticleGoogle Scholar


© Garcia-Trinidad et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.